GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (NAS:CSCI) » Definitions » Cyclically Adjusted Book per Share

CSCI (Cosciens Biopharma) Cyclically Adjusted Book per Share : $9.24 (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Cosciens Biopharma Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cosciens Biopharma's adjusted book value per share for the three months ended in Mar. 2025 was $3.224. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.24 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Cosciens Biopharma's average Cyclically Adjusted Book Growth Rate was 7.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 21.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 51.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cosciens Biopharma was 150.00% per year. The lowest was 17.60% per year. And the median was 56.70% per year.

As of today (2025-06-18), Cosciens Biopharma's current stock price is $3.5681. Cosciens Biopharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $9.24. Cosciens Biopharma's Cyclically Adjusted PB Ratio of today is 0.39.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cosciens Biopharma was 132.34. The lowest was 0.27. And the median was 3.83.


Cosciens Biopharma Cyclically Adjusted Book per Share Historical Data

The historical data trend for Cosciens Biopharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma Cyclically Adjusted Book per Share Chart

Cosciens Biopharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.50 6.70 8.74 11.05 9.92

Cosciens Biopharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.35 9.88 10.23 9.92 9.24

Competitive Comparison of Cosciens Biopharma's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Cosciens Biopharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosciens Biopharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cosciens Biopharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cosciens Biopharma's Cyclically Adjusted PB Ratio falls into.


;
;

Cosciens Biopharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cosciens Biopharma's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.224/129.1809*129.1809
=3.224

Current CPI (Mar. 2025) = 129.1809.

Cosciens Biopharma Quarterly Data

Book Value per Share CPI Adj_Book
201506 1.709 100.500 2.197
201509 2.148 100.421 2.763
201512 3.848 99.947 4.974
201603 4.773 101.054 6.102
201606 5.657 102.002 7.164
201609 9.260 101.765 11.755
201612 9.432 101.449 12.010
201703 9.764 102.634 12.290
201706 10.237 103.029 12.835
201709 10.904 103.345 13.630
201712 10.055 103.345 12.569
201803 9.715 105.004 11.952
201806 9.489 105.557 11.613
201809 9.670 105.636 11.825
201812 9.375 105.399 11.490
201903 9.342 106.979 11.281
201906 9.280 107.690 11.132
201909 9.156 107.611 10.991
201912 9.359 107.769 11.218
202003 9.057 107.927 10.841
202006 9.841 108.401 11.727
202009 10.127 108.164 12.095
202012 10.406 108.559 12.383
202103 10.740 110.298 12.579
202106 11.235 111.720 12.991
202109 11.299 112.905 12.928
202112 11.861 113.774 13.467
202203 12.764 117.646 14.016
202206 13.042 120.806 13.946
202209 12.622 120.648 13.515
202212 12.888 120.964 13.763
202303 12.825 122.702 13.502
202306 12.642 124.203 13.149
202309 11.928 125.230 12.304
202312 11.383 125.072 11.757
202403 10.406 126.258 10.647
202406 8.565 127.522 8.676
202409 6.411 127.285 6.507
202412 4.190 127.364 4.250
202503 3.224 129.181 3.224

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Cosciens Biopharma  (NAS:CSCI) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cosciens Biopharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.5681/9.24
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cosciens Biopharma was 132.34. The lowest was 0.27. And the median was 3.83.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cosciens Biopharma Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Cosciens Biopharma's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosciens Biopharma Business Description

Industry
Traded in Other Exchanges
Address
c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, P.O. Box 53, Toronto, ON, CAN, M5K 1E7
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.